- Home
- Labeler Index
- Bioverativ Therapeutics Inc.
- 71104-922
- NDC Crossover: 71104-922 Alprolix
NDC Crossover 71104-922 Alprolix
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching
The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.
Explore similar products to 71104-922 – Alprolix, a plasma derivative. This list includes other cross-matching products that share:
- The same product name: Alprolix
- OR Generic name: Coagulation Factor Ix (recombinant), Fc Fusion Protein
- AND the same Administration Route:
- OR Dosage Form: kit
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
|---|---|---|---|---|---|---|
| 71104-911 | Alprolix | Coagulation Factor Ix (recombinant), Fc Fusion Protein | Kit | Bioverativ Therapeutics Inc. | Plasma Derivative | |
| 71104-933 | Alprolix | Coagulation Factor Ix (recombinant), Fc Fusion Protein | Kit | Bioverativ Therapeutics Inc. | Plasma Derivative | |
| 71104-944 | Alprolix | Coagulation Factor Ix (recombinant), Fc Fusion Protein | Kit | Bioverativ Therapeutics Inc. | Plasma Derivative | |
| 71104-966 | Alprolix | Coagulation Factor Ix (recombinant), Fc Fusion Protein | Kit | Bioverativ Therapeutics Inc. | Plasma Derivative | |
| 71104-977 | Alprolix | Coagulation Factor Ix (recombinant), Fc Fusion Protein | Kit | Bioverativ Therapeutics Inc. | Plasma Derivative |
